Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129595649> ?p ?o ?g. }
- W2129595649 endingPage "649" @default.
- W2129595649 startingPage "640" @default.
- W2129595649 abstract "Background & Aims Patients with cirrhosis are prone to infection which is a frequent precipitant of hepatic encephalopathy (HE). Clinical studies have examined the importance of inflammation and infection in modulating the manifestation of symptoms of HE in acute liver failure and patients with cirrhosis and minimal/low grade HE. It would be logical to presume that this relationship persists in patients who develop severe HE in cirrhosis although this has not been examined to date. Methods We report the findings of a prospective audit of 100 consecutive patients with cirrhosis admitted between Jan 2000 and March 2008 to a liver Intensive Care Unit (ICU) where HE was the primary indication for admission (59% Grade 3; 41% Grade 4). Haematological and microbiological data were collected at ICU admission, and organ scores and outcomes were recorded. Results 46% of patients had positive cultures taken within ±48 h from admission to ICU [25% blood] and a further 22% were culture negative but had evidence of systemic inflammation (SIRS). SIRS score (p = 0.03) and SOFA score (p = 0.006) were significantly higher in those patients with Grade 4 HE, who were also less likely to survive (p <0.001). HE grade/coma score did not correlate with ammonia, biochemistry or MELD score. Fifty-two percent of patients survived their ICU stay while the remainder developed progressive multiorgan failure and died; 38% survived to discharge, and 16% were transplanted. Conclusions These data support an association between infection/SIRS and not ammonia, in patients with cirrhosis that develop severe HE. The presence or absence of infection/SIRS did not determine survival. Patients with cirrhosis are prone to infection which is a frequent precipitant of hepatic encephalopathy (HE). Clinical studies have examined the importance of inflammation and infection in modulating the manifestation of symptoms of HE in acute liver failure and patients with cirrhosis and minimal/low grade HE. It would be logical to presume that this relationship persists in patients who develop severe HE in cirrhosis although this has not been examined to date. We report the findings of a prospective audit of 100 consecutive patients with cirrhosis admitted between Jan 2000 and March 2008 to a liver Intensive Care Unit (ICU) where HE was the primary indication for admission (59% Grade 3; 41% Grade 4). Haematological and microbiological data were collected at ICU admission, and organ scores and outcomes were recorded. 46% of patients had positive cultures taken within ±48 h from admission to ICU [25% blood] and a further 22% were culture negative but had evidence of systemic inflammation (SIRS). SIRS score (p = 0.03) and SOFA score (p = 0.006) were significantly higher in those patients with Grade 4 HE, who were also less likely to survive (p <0.001). HE grade/coma score did not correlate with ammonia, biochemistry or MELD score. Fifty-two percent of patients survived their ICU stay while the remainder developed progressive multiorgan failure and died; 38% survived to discharge, and 16% were transplanted. These data support an association between infection/SIRS and not ammonia, in patients with cirrhosis that develop severe HE. The presence or absence of infection/SIRS did not determine survival." @default.
- W2129595649 created "2016-06-24" @default.
- W2129595649 creator A5000092638 @default.
- W2129595649 creator A5009574999 @default.
- W2129595649 creator A5010010256 @default.
- W2129595649 creator A5013434946 @default.
- W2129595649 creator A5021682841 @default.
- W2129595649 creator A5025986368 @default.
- W2129595649 creator A5033429353 @default.
- W2129595649 creator A5038855294 @default.
- W2129595649 creator A5070109944 @default.
- W2129595649 date "2011-04-01" @default.
- W2129595649 modified "2023-10-16" @default.
- W2129595649 title "Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis" @default.
- W2129595649 cites W101668356 @default.
- W2129595649 cites W1603121691 @default.
- W2129595649 cites W1608215573 @default.
- W2129595649 cites W1898928487 @default.
- W2129595649 cites W1965452105 @default.
- W2129595649 cites W1972164720 @default.
- W2129595649 cites W1977378686 @default.
- W2129595649 cites W1977994299 @default.
- W2129595649 cites W1979486195 @default.
- W2129595649 cites W1982049192 @default.
- W2129595649 cites W1982407433 @default.
- W2129595649 cites W1992634855 @default.
- W2129595649 cites W1993089591 @default.
- W2129595649 cites W1996907628 @default.
- W2129595649 cites W2001087077 @default.
- W2129595649 cites W2004944131 @default.
- W2129595649 cites W2015505702 @default.
- W2129595649 cites W2015669226 @default.
- W2129595649 cites W2029771605 @default.
- W2129595649 cites W2039615827 @default.
- W2129595649 cites W2055719070 @default.
- W2129595649 cites W2060123467 @default.
- W2129595649 cites W2069243984 @default.
- W2129595649 cites W2073238470 @default.
- W2129595649 cites W2082410952 @default.
- W2129595649 cites W2082748241 @default.
- W2129595649 cites W2087481743 @default.
- W2129595649 cites W2088910001 @default.
- W2129595649 cites W2103708381 @default.
- W2129595649 cites W2109922371 @default.
- W2129595649 cites W2112485885 @default.
- W2129595649 cites W2112610029 @default.
- W2129595649 cites W2127244067 @default.
- W2129595649 cites W2138271592 @default.
- W2129595649 cites W2148096965 @default.
- W2129595649 cites W2155487694 @default.
- W2129595649 cites W2158736090 @default.
- W2129595649 cites W2410390075 @default.
- W2129595649 cites W2462821501 @default.
- W2129595649 cites W2599527603 @default.
- W2129595649 cites W325120109 @default.
- W2129595649 doi "https://doi.org/10.1016/j.jhep.2010.07.045" @default.
- W2129595649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21163546" @default.
- W2129595649 hasPublicationYear "2011" @default.
- W2129595649 type Work @default.
- W2129595649 sameAs 2129595649 @default.
- W2129595649 citedByCount "209" @default.
- W2129595649 countsByYear W21295956492012 @default.
- W2129595649 countsByYear W21295956492013 @default.
- W2129595649 countsByYear W21295956492014 @default.
- W2129595649 countsByYear W21295956492015 @default.
- W2129595649 countsByYear W21295956492016 @default.
- W2129595649 countsByYear W21295956492017 @default.
- W2129595649 countsByYear W21295956492018 @default.
- W2129595649 countsByYear W21295956492019 @default.
- W2129595649 countsByYear W21295956492020 @default.
- W2129595649 countsByYear W21295956492021 @default.
- W2129595649 countsByYear W21295956492022 @default.
- W2129595649 countsByYear W21295956492023 @default.
- W2129595649 crossrefType "journal-article" @default.
- W2129595649 hasAuthorship W2129595649A5000092638 @default.
- W2129595649 hasAuthorship W2129595649A5009574999 @default.
- W2129595649 hasAuthorship W2129595649A5010010256 @default.
- W2129595649 hasAuthorship W2129595649A5013434946 @default.
- W2129595649 hasAuthorship W2129595649A5021682841 @default.
- W2129595649 hasAuthorship W2129595649A5025986368 @default.
- W2129595649 hasAuthorship W2129595649A5033429353 @default.
- W2129595649 hasAuthorship W2129595649A5038855294 @default.
- W2129595649 hasAuthorship W2129595649A5070109944 @default.
- W2129595649 hasConcept C100136789 @default.
- W2129595649 hasConcept C120665830 @default.
- W2129595649 hasConcept C121332964 @default.
- W2129595649 hasConcept C126322002 @default.
- W2129595649 hasConcept C141071460 @default.
- W2129595649 hasConcept C17624336 @default.
- W2129595649 hasConcept C2776252253 @default.
- W2129595649 hasConcept C2776376669 @default.
- W2129595649 hasConcept C2776914184 @default.
- W2129595649 hasConcept C2777214474 @default.
- W2129595649 hasConcept C2778384902 @default.
- W2129595649 hasConcept C2778621155 @default.
- W2129595649 hasConcept C2780325230 @default.
- W2129595649 hasConcept C2781090800 @default.
- W2129595649 hasConcept C71924100 @default.